Medtronic ROA 2006-2019 | MDT
Current and historical return on assets (ROA) values for Medtronic (MDT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Medtronic ROA for the three months ending October 31, 2019 was 8.10%.
| Medtronic ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2019-10-31 | $4.67B | $91.05B | 5.18% |
| 2019-07-31 | $4.42B | $91.27B | 4.94% |
| 2019-04-30 | $4.63B | $89.69B | 5.20% |
| 2019-01-31 | $4.92B | $88.73B | 5.50% |
| 2018-10-31 | $2.26B | $88.15B | 2.48% |
| 2018-07-31 | $3.16B | $89.72B | 3.41% |
| 2018-04-30 | $3.10B | $91.39B | 3.25% |
| 2018-01-31 | $2.81B | $95.80B | 2.88% |
| 2017-10-31 | $5.02B | $94.46B | 5.12% |
| 2017-07-31 | $4.12B | $100.25B | 4.16% |
| 2017-04-30 | $4.03B | $99.86B | 4.08% |
| 2017-01-31 | $3.97B | $97.58B | 4.03% |
| 2016-10-31 | $4.24B | $98.41B | 4.25% |
| 2016-07-31 | $3.65B | $98.60B | 3.59% |
| 2016-04-30 | $3.54B | $99.64B | 3.44% |
| 2016-01-31 | $2.43B | $102.71B | 2.32% |
| 2015-10-31 | $2.32B | $104.95B | 2.49% |
| 2015-07-31 | $2.62B | $104.63B | 3.44% |
| 2015-04-30 | $2.68B | $106.69B | 4.49% |
| 2015-01-31 | $3.12B | $55.23B | 7.37% |
| 2014-10-31 | $2.91B | $38.78B | 7.68% |
| 2014-07-31 | $2.98B | $37.55B | 8.00% |
| 2014-04-30 | $3.07B | $37.94B | 8.36% |
| 2014-01-31 | $3.59B | $37.23B | 9.99% |
| 2013-10-31 | $3.81B | $36.47B | 10.79% |
| 2013-07-31 | $3.56B | $34.97B | 10.25% |
| 2013-04-30 | $3.47B | $34.90B | 10.12% |
| 2013-01-31 | $3.49B | $34.95B | 10.34% |
| 2012-10-31 | $3.44B | $33.96B | 10.41% |
| 2012-07-31 | $3.66B | $33.25B | 11.28% |
| 2012-04-30 | $3.62B | $32.82B | 11.34% |
| 2012-01-31 | $3.40B | $31.91B | 10.85% |
| 2011-10-31 | $3.39B | $31.75B | 10.93% |
| 2011-07-31 | $3.09B | $31.09B | 10.15% |
| 2011-04-30 | $3.10B | $30.68B | 10.39% |
| 2011-01-31 | $3.28B | $30.60B | 11.23% |
| 2010-10-31 | $3.18B | $29.31B | 11.44% |
| 2010-07-31 | $3.48B | $28.66B | 13.12% |
| 2010-04-30 | $3.10B | $28.09B | 12.26% |
| 2010-01-31 | $2.25B | $25.17B | 9.30% |
| 2009-10-31 | $2.11B | $24.28B | 8.97% |
| 2009-07-31 | $1.79B | $23.57B | 7.79% |
| 2009-04-30 | $2.07B | $23.59B | 9.09% |
| 2009-01-31 | $2.69B | $22.76B | 11.98% |
| 2008-10-31 | $2.07B | $22.03B | 9.36% |
| 2008-07-31 | $2.19B | $22.73B | 10.06% |
| 2008-04-30 | $2.14B | $22.20B | 10.20% |
| 2008-01-31 | $2.23B | $21.41B | 10.99% |
| 2007-10-31 | $2.86B | $20.59B | 14.44% |
| 2007-07-31 | $2.88B | $19.66B | 14.83% |
| 2007-04-30 | $2.80B | $19.51B | 14.34% |
| 2007-01-31 | $2.73B | $19.57B | 13.94% |
| 2006-10-31 | $2.69B | $18.90B | 13.95% |
| 2006-07-31 | $2.83B | $20.18B | 14.88% |
| 2006-04-30 | $2.55B | $19.67B | 14.02% |
| 2006-01-31 | $2.00B | $18.34B | 11.50% |
| 2005-10-31 | $1.88B | $17.77B | 11.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $159.545B | $30.557B |
| Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $157.393B | 28.71 |
| Stryker (SYK) | United States | $79.374B | 26.69 |
| Boston Scientific (BSX) | United States | $61.719B | 29.13 |
| Baxter (BAX) | United States | $45.812B | 27.78 |
| Essilor Luxottica (ESLOY) | France | $35.128B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.725B | 19.27 |
| Lonza Group Ag (LZAGY) | Switzerland | $28.134B | 0.00 |
| Coloplast (CLPBY) | Denmark | $27.648B | 42.67 |
| Terumo (TRUMY) | Japan | $26.986B | 0.00 |
| ResMed (RMD) | United States | $23.088B | 42.59 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $21.557B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $20.017B | 0.00 |
| Insulet (PODD) | United States | $11.669B | 555.18 |
| Bio-Rad Laboratories (BIO) | United States | $11.282B | 54.15 |
| Canopy Growth (CGC) | Canada | $8.676B | 0.00 |
| Perrigo (PRGO) | Ireland | $8.033B | 14.98 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.750B | 22.78 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.357B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.158B | 0.00 |
| Haemonetics (HAE) | United States | $5.770B | 38.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| NuVasive (NUVA) | United States | $4.065B | 32.01 |
| ICU Medical (ICUI) | United States | $3.960B | 25.81 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.923B | 0.00 |
| Neogen (NEOG) | United States | $3.757B | 62.53 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.675B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.113B | 0.00 |
| Quidel (QDEL) | United States | $3.020B | 28.66 |
| National Vision Holdings (EYE) | United States | $2.597B | 58.63 |
| Aurora Cannabis (ACB) | Canada | $2.321B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.887B | 0.00 |
| AtriCure (ATRC) | United States | $1.513B | 0.00 |
| InMode (INMD) | Israel | $1.440B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.364B | 0.00 |
| Aphria (APHA) | $1.331B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.206B | 24.09 |
| NanoString Technologies (NSTG) | United States | $1.101B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.043B | 19.54 |
| PetIQ (PETQ) | United States | $0.869B | 21.20 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.806B | 30.87 |
| Lantheus Holdings (LNTH) | United States | $0.742B | 18.54 |
| LeMaitre Vascular (LMAT) | United States | $0.737B | 41.43 |
| Omeros (OMER) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.675B | 0.00 |
| Cerus (CERS) | United States | $0.571B | 0.00 |
| Surmodics (SRDX) | United States | $0.560B | 58.06 |
| MacroGenics (MGNX) | United States | $0.551B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.509B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.507B | 30.44 |
| HEXO (HEXO) | $0.441B | 0.00 | |
| Meridian Bioscience (VIVO) | United States | $0.424B | 14.54 |
| Utah Medical Products (UTMD) | United States | $0.392B | 28.37 |
| Zynex (ZYXI) | United States | $0.350B | 39.59 |
| Owens & Minor (OMI) | United States | $0.346B | 12.81 |
| BioLife Solutions (BLFS) | United States | $0.332B | 135.08 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.285B | 0.00 |
| Bovie Medical (APYX) | United States | $0.277B | 0.00 |
| Female Health (VERU) | United States | $0.273B | 0.00 |
| Vapotherm (VAPO) | United States | $0.259B | 0.00 |
| United Health Products (UEEC) | United States | $0.233B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.225B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.209B | 22.04 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.178B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.177B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.166B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.149B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 9.43 |
| Chimerix (CMRX) | United States | $0.125B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Surface Oncology (SURF) | United States | $0.094B | 0.00 |
| United-Guardian (UG) | United States | $0.089B | 22.57 |
| MRI Interventions (MRIC) | United States | $0.086B | 0.00 |
| Nephros (NEPH) | United States | $0.074B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| FSD PHARMA INC (HUGE) | $0.051B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.023B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.023B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.014B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.008B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
